Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils

Food and Chemical Toxicology

Volumn 52, Issue , 2013, Pages 53-60

  Ying, Hua Zhong ^a   Liu, Yue Huan ^a   Yu, Bing ^b   Wang, Zhi Yuan ^a   Zang, Jia Na ^b   Yu, Chen Huan ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; INOS; Lipid profiles; NF B; Sirt1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; QUERCETIN; SIRTUIN 1; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SCREENING; GERBIL; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; LIPID STORAGE; LIVER CELL CULTURE; LIVER PROTECTION; LOW DRUG DOSE; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN EXPRESSION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHOLESTEROL; CHOLESTEROL, LDL; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY LIVER; FIBROSIS; GERBILLINAE; HEPATOCYTES; HYPERLIPIDEMIAS; INTERLEUKIN-6; LIVER; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; QUERCETIN; RATS; SIRTUIN 1; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; GERBILLINAE; RATTUS;

EID: 84869869189     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.10.030     Document Type: Article

References (57)

1. Alsheikh-Ali A.A., Kuvin J.T., Karas R.H. Risk of adverse events with fibrates. Am. J. Cardiol. 2004, 94:935-938.
2. Azuma K., Ippoushi K., Terao J. Evaluation of tolerable levels of dietary quercetin for exerting its antioxidative effect in high cholesterol-fed rats. Food Chem. Toxicol. 2010, 48:1117-1122.
3. Bai L., Pang W.J., Yang Y.J., Yang G.S. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol. Cell. Biochem. 2008, 307:129-140.
4. Bakhshaeshi M., Khaki A., Fathiazad F., Khaki A.A., Ghadamkheir E. Anti-oxidative role of quercetin derived from Allium cepa on aldehyde oxidase (OX-LDL) and hepatocytes apoptosis in streptozotocin-induced diabetic rat. Asian Pac. J. Trop. Biomed. 2012, 2:528-531.
5. Bleich E.M., Martin M., Bleich A., Klos A. The Mongolian gerbil as a model for inflammatory bowel disease. Int. J. Exp. Pathol. 2010, 91:281-287.
6. Boots A.W., Haenen G.R.M.M., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585:325-337.
7. Cai M., Shin B.Y., Kim D.H., Kim J.M., Park S.J., Park C.S., Won D.H., Hong N.D., Kang D.H., Yutaka Y., Ryu J.H. Neuroprotective effects of a traditional herbal prescription on transient cerebral global ischemia ingerbils. J. Ethnopharmacol. 2011, 138:723-730.
8. Chan S.T., Chuang C.H., Yeh C.L., Liao J.W., Liu K.L., Tseng M.J., Yeh S.L. Quercetin supplementation suppresses the secretion of pro-inflammatory cytokines in the lungs of Mongolian gerbils and in A549 cells exposed to benzo[a]pyrene alone or in combination with β-carotene: in vivo and ex vivo studies. J. Nutr. Biochem. 2012, 23:179-185.
9. Chung S., Yao H., Caito S., Hwang J., Arunachalam G., Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch. Biochem. Biophys. 2010, 501:79-90.
10. Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332:1519-1523.
11. Duchnowicz P., Broncel M., Podsedek A., Koter-Michalak M. Hypolipidemic and antioxidant effects of hydroxycinnamic acids, quercetin, and cyanidin 3-glucoside in hypercholesterolemic erythrocytes (in vitro study). Eur. J. Nutr. 2012, 51:435-443.
12. El-Beshbishy H.A., Singab A.N.B., Sinkkonen J., Pihlaja K. Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sci. 2006, 78:2724-2733.
13. Feng L.J., Yu C.H., Ying K.J., Hua J., Dai X.Y. Hypolipidemic and antioxidant effects of total flavonoids of Perilla frutescens leaves in hyperlipidemia rats induced by high-fat diet. Food Res. Int. 2011, 44:404-409.
14. Haddy N., Sass C., Droesch S., Zaiou M., Siest G., Ponthieux A., Lambert D., Visvikis S. IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003, 170:277-283.
15. Hu Q.H., Zhang X., Pan Y., Li Y.C., Kong L.D. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochem. Pharmacol. 2012, 84:113-125.
16. Jadeja R.N., Thounaojam M.C., Dandekar D.S., Devkar R.V., Ramachandran A.V. Clerodendron glandulosum. Coleb extract ameliorates high fat diet/fatty acid induced lipotoxicity in experimental models of non-alcoholic steatohepatitis. Food Chem. Toxicol. 2010, 48:3424-3431.
17. Kanter M., Aktas C., Erboga M. Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food Chem. Toxicol. 2012, 50:719-725.
18. Kebieche M., Lakroun Z., Lahouel M., Bouayed J., Meraihi Z., Soulimani R. Evaluation of epirubicin-induced acute oxidative stress toxicity in rat liver cells and mitochondria, and the prevention of toxicity through quercetin administration. Exp. Toxicol. Pathol. 2009, 61:161-167.
19. Khaki A., Fathiazad F., Nouri M., Khaki A., Maleki N.A., Khamnei H.J., Ahmadi P. Beneficial effects of quercetin on sperm parameters in streptozotocin- induced diabetic male rats. Phytother. Res. 2010, 24:1285-1291.
20. Kleemann R., Verschuren L., Morrison M., Zadelaar S., van Erk M.J., Wielinga P.Y., Kooistra T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 2011, 218:44-52.
21. Lei Y.F., Chen J.L., Wei H., Xiong C.M., Zhang Y.H., Ruan J.L. Hypolipidemic and anti-inflammatory properties of Abacopterin A from Abacopteris penangiana in high-fat diet-induced hyperlipidemia mice. Food Chem. Toxicol. 2011, 49:3206-3210.
22. Liu C.M., Zheng Y.L., Lu J., Zhang Z.F., Fan S.H., Wu D.M., Ma J.Q. Quercetin protects rat liver against lead-induced oxidative stress and apoptosis. Environ. Toxicol. Phar. 2010, 29:158-166.
23. Liu S., Hou W., Yao P., Li N., Zhang B., Hao L., Nüssler A.K., Liu L. Heme oxygenase-1 mediates the protective role of quercetin against ethanol-induced rat hepatocytes oxidative damage. Toxicol. In Vitro 2012, 26:74-80.
24. Loguercio C., Andreone P., Brisc C., Brisc M.C., Bugianesi E., Chiaramonte M., Cursaro C., Danila M., de Sio I., Floreani A., Freni M.A., Grieco A., Groppo M., Lazzari R., Lobello S., Lorefice E., Margotti M., Miele L., Milani S., Okolicsanyi L., Palasciano G., Portincasa P., Saltarelli P., Smedile A., Somalvico F., Spadaro A., Sporea I., Sorrentino P., Vecchione R., Tuccillo C., Del Vecchio Blanco C., Federico A. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic. Biol. Med. 2012, 52:1658-1665.
25. Mantena S.K., King A.L., Andringa K.K., Eccleston H.B., Bailey S.M. Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic. Biol. Med. 2008, 44:1259-1272.
26. Mariee A.D., Abd-Allah G.M., El-Beshbishy H.A. Protective effect of dietary flavonoid quercetin against lipemic-oxidative hepatic injury in hypercholesterolemic rats. Pharm. Biol. 2012, 50:1019-1025.
27. Martin H.R., Shakya K.P., Muthupalani S., Ge Z., Klei T.R., Whary M.T., Fox J.G. Brugia filariasis differentially modulates persistent Helicobacter pylori gastritis in the gerbil model. Microbes Infect. 2010, 12:748-758.
28. Miele L., Forgione A., Gasbarrini G., Grieco A. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Transl. Res. 2007, 149:114-125.
29. Mladěnka P., Zatloukalová L., Filipský T., Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic. Biol. Med. 2010, 49:963-975.
30. Musso G., Gambino R., Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 2009, 48:1-26.
31. Narasimhan S., Gokulakrishnan K., Sampathkumar R., Farooq S., Ravikumar R., Mohan V., Balasubramanyam M. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin. Biochem. 2010, 43:815-821.
32. OrŠolić N., Gajski G., Garaj-Vrhovac V., Dikić D., Prskalo Z.Š., Sirovina D. DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice. Eur. J. Pharmacol. 2011, 656:110-118.
33. Pasarín M., Abraldes J.G., Rodríguez-Vilarrupla A., Mura V.L., García-Pagán J.C., Bosch J. Insulin resistance and liver microcirculation in a rat model of early NAFLD. J. Hepatol. 2011, 55:1095-1102.
34. Purushotham A., Schug T.T., Xu Q., Surapureddi S., Guo X., Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009, 9:327-338.
35. Qin Y., Tian Y.P. Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. Lipids Health Dis. 2010, 9:78.
36. Rahman I., Kinnula V.L., Gorbunova V., Yao H. Sirt1 as a therapeutic target in inflammaging of the pulmonary disease. Prev. Med. 2012, 54:S20-S28.
37. Ramana B.V., Kumar V.V., Krishna P.N.R., Kumar C.S., Reddy P.U.M., Raju T.N. Effect of quercetin on galactose-induced hyperglycaemic oxidative stress in hepatic and neuronal tissues of Wistar rats. Acta Diabetol. 2006, 43:135-141.
38. Rolo A.P., Teodoro J.S., Palmeira C.M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2012, 52:59-69.
39. Salamone F., Galvano F., Cappello F., Mangiameli A., Barbagallo I., Volti G.L. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl. Res. 2012, 159:477-486.
40. Sergent T., Vanderstraeten J., Winand J., Beguin P., Schneider Y.J. Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem. 2012, 135:68-73.
41. Shetty A.K., Rashmi R., Rajan M.G.R., Sambaiah K., Salimath P.V. Antidiabetic influence of quercetin in streptozotocin-induced diabetic. Nutr. Res. 2004, 24:373-381.
42. Sturzeneker M.C.S., Ioshii S.O., Baroncini L.A.V., Précoma D.B. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia. Atherosclerosis 2011, 216:97-102.
43. Tang B.L. Sirt1's systemic protective roles and its promise as a target in antiaging medicine. Transl. Res. 2011, 157:276-284.
44. Tang B.L., Chua C.E.L. Is systemic activation of Sirt1 beneficial for ageing- associated metabolic disorders?. Biochem. Biophys. Res. Commun. 2010, 391:6-10.
45. Tang Y., Gao C., Xing M., Li Y., Zhu L., Wang D., Yang X., Liu L., Yao P. Quercetin prevents ethanol-induced dyslipidemia and mitochondrial oxidative damage. Food Chem. Toxicol. 2012, 50:1194-1200.
46. Thounaojam M.C., Jadeja R.N., Dandekar D.S., Devkar R.V., Ramachandran A.V. Sida rhomboidea. Roxb extract alleviates pathophysiological changes in experimental in vivo and in vitro models of high fat diet/fatty acid induced non-alcoholic steatohepatitis. Exp. Toxicol. Pathol. 2012, 64:217-224.
47. Thounaojam M.C., Jadeja R.N., Devkar R.V., Ramachandran A.V. Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics. J. Appl. Biomed. 2012, 10:119-136.
48. Tokushige K., Takakura M., Tsuchiya-Matsushita N., Taniai M., Hashimoto E., Shiratori K. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J. Hepatol. 2007, 46:1104-1110.
49. Tseng P.H., Liu C.J., Kao J.H., Shun C.T., Chen P.J., Chen D.S. Disease progression in a patient with nonalcoholic steatohepatitis. J. Formos. Med. Assoc. 2008, 107:816-821.
50. Wein S., Behm N., Petersen R.K., Kristiansen K., Wolffram S. Quercetin enhances adiponectin secretion by a PPAR-γ independent mechanism. Eur. J. Pharm. Sci. 2010, 41:16-22.
51. Yang E.J., Kim S.I., Park S.Y., Bang H.Y., Jeong J.H., So J.H., Rhee I.K., Song K.S. Fermentation enhances the in vitro antioxidative effect of onion (Allium cepa) via an increase in quercetin content. Food Chem. Toxicol. 2012, 50:2042-2048.
52. Younossi Z.M., Kleiner D.E., Gramlich T.L., Boparai N. Application of NIDDK nash pathologic protocol to patients with non-alcoholic fatty liver disease. Gastroenterology 2000, 118:A974.
53. Yousef M.I., Omar S.A.M., El-Guendi M.I., Abdelmegid L.A. Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem. Toxicol. 2010, 48:3246-3261.
54. Zaitone S., Hassan N., El-Orabi N., El-Awady El.-S. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. Eur. J. Pharmacol. 2011, 662:70-77.
55. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R., Webb M., Blendis L., Halpern Z., Oren R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J. Hepatol. 2007, 47:711-717.
56. + metabolism and signaling to the control of cellular functions. BBA-Proteins Proteom. 2010, 1804:1666-1675.
57. Zois C.D., Baltayiannis G.H., Karayiannis P., Tsianos E.V. Systematic review: hepatic fibrosis - regression with therapy. Aliment. Pharmacol. Ther. 2008, 28:1175-1187.